Kevin Yau
Overview
Explore the profile of Kevin Yau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
386
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Glucagon-like peptide-1 receptor agonists to improve cardiorenal outcomes: data from FLOW and beyond
Faruque L, Yau K, Cherney D
Curr Opin Nephrol Hypertens
. 2025 Mar;
PMID: 40047207
Purpose Of Review: Glucagon-like peptide-1 receptor agonists (GLP1RA), initially approved for glycemic control in type 2 diabetes mellitus (T2DM), have emerged as agents for weight loss, cardiovascular and kidney protection....
2.
Atiquzzaman M, Er L, Djurdjev O, Zheng Y, Wong M, Birks P, et al.
Nephrol Dial Transplant
. 2025 Feb;
PMID: 39979022
Background: We investigated the long-term effect of COVID-19 on eGFR trajectory and the association with progression to kidney failure in patients with CKD. Methods: Patients living with non-dialysis dependent CKD...
3.
Nardone M, Yau K, Kugathasan L, Odutayo A, Mohsen M, Ouimet J, et al.
Nephrol Dial Transplant
. 2025 Feb;
40(Supplement_1):i47-i58.
PMID: 39907540
Abstract: Despite recent advancements in the treatment of chronic kidney disease (CKD), identifying novel therapies beyond guideline-directed therapies that reduce residual cardiorenal risk remains imperative. In this review, we highlight...
4.
Bota S, McArthur E, Naylor K, Blake P, Yau K, Hladunewich M, et al.
Kidney360
. 2024 Aug;
5(8):1116-1125.
PMID: 39151048
No abstract available.
5.
Daza J, Soares Bezerra L, Santamaria L, Rueda-Esteban R, Bantel H, Girala M, et al.
Ann Hepatol
. 2024 Aug;
30(1):101537.
PMID: 39147133
Introduction And Objectives: Autoimmune liver diseases (AILDs) are rare and require precise evaluation, which is often challenging for medical providers. Chatbots are innovative solutions to assist healthcare professionals in clinical...
6.
Yau K, Cherney D, van Raalte D, Wever B
Kidney Int
. 2024 May;
105(6):1168-1172.
PMID: 38777402
No abstract available.
7.
Enilama O, MacDonald C, Thompson P, Khan U, Allu S, Beaucage M, et al.
Can J Kidney Health Dis
. 2024 Apr;
11:20543581241242550.
PMID: 38628809
Background: People living with chronic kidney disease (CKD) face an increased risk of severe outcomes such as hospitalization or death from COVID-19. COVID-19 vaccination is a vital approach to mitigate...
8.
Nardone M, Sridhar V, Yau K, Odutayo A, Cherney D
Nephrol Dial Transplant
. 2024 Mar;
39(9):1392-1403.
PMID: 38425090
Volume overload represents a hallmark clinical feature linked to the development and progression of heart failure (HF). Alleviating signs and symptoms of volume overload represents a foundational HF treatment target...
9.
Yau K, Kuah R, Cherney D, Lam T
Nat Rev Endocrinol
. 2024 Feb;
20(6):321-335.
PMID: 38351406
Obesity is strongly associated with the development of diabetes mellitus and chronic kidney disease (CKD), but there is evidence for a bidirectional relationship wherein the kidney also acts as a...
10.
Enilama O, Yau K, Er L, Atiquzzaman M, Oliver M, Romney M, et al.
Can J Kidney Health Dis
. 2024 Jan;
11:20543581231224127.
PMID: 38292817
Background: Chronic kidney disease (CKD) is associated with a lower serologic response to vaccination compared to the general population. There is limited information regarding the serologic response to coronavirus disease...